<DOC>
	<DOC>NCT00180401</DOC>
	<brief_summary>The purpose of this study is to compare the benefit of cardiac resynchronization therapy (CRT)-therapy in patients with a QRS-complex of 120-150 ms to patients with a QRS-complex of &gt; 150 ms.</brief_summary>
	<brief_title>MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms</brief_title>
	<detailed_description>The objective of this study is to compare the benefit of CRT-therapy in patients with a QRS-complex of 120-150 ms to patients with a QRS-complex of &gt; 150 ms within 12 months. A benefit is defined as change in quality of life and change in physical ability.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients with cardiac resynchronization therapy with a defibrillator (CRTD) or cardiac resynchronization therapy pacemakers (CRTP) system New York Heart Association (NYHA) III Ejection fraction (EF) below 35% Optimised medical therapy QRScomplex above 120 ms Patients with CRTP and atrial fibrillation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>